FDA Inspection 879374 — Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. on April 25, 2014 in Hangzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 25, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)